USPTO Art Unit 1616 Prosecution Statistics

Art Unit Information

Art Unit: 1616
Group: 1610
Tech Center: 1600
Total Cases: 16,327
Last Active: May 2025

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19210210Herbicidal compositions comprising acetochlorMay 2025December 2025Allow710NoNo
19069616AGRICULTURAL COMPOSITIONS COMPRISING REMODELED NITROGEN FIXING MICROBESMarch 2025August 2025Allow510YesNo
19059897Herbicidal compositions comprising dimethenamidFebruary 2025September 2025Allow710YesNo
19054100Herbicidal compositions comprising imazethapyrFebruary 2025September 2025Allow720YesNo
18985130MULTIFUNCTIONAL MICROBIAL AGENT AND APPLICATIONS THEREOFDecember 2024March 2025Allow300NoNo
18975237Plant Food to Enhance the Nutritional Value of Pollen and Nectar of Plants to Attract Bees, Butterflies and Other PollinatorsDecember 2024August 2025Allow801NoNo
18969037PRESSURIZED INHALATION COMPOSITION OF TIOTROPIUMDecember 2024November 2025Allow1120YesNo
18967337PLANT DERIVED FOOD PRESERVATIVEDecember 2024July 2025Allow711YesNo
18965257DRY POWDER ESKETAMINE COMPOSITION FOR USE IN THE TREATMENT OF BIPOLAR DEPRESSION BY PULMONARY ADMINISTRATIONDecember 2024September 2025Allow910YesNo
18962472Herbicidal compositions comprising glufosinateNovember 2024September 2025Allow1020YesNo
18947430SODIUM THIOSULFATE-CONTAINING PHARMACEUTICAL COMPOSITIONSNovember 2024April 2025Allow510YesNo
18909414POLYMERIC ANTI-MICROBIAL FILMOctober 2024December 2024Allow200NoNo
18908215Termite Trailing and Recruitment Product and ProcessOctober 2024April 2025Allow610YesNo
18903119PHARMACEUTICAL COMPOSITIONSOctober 2024July 2025Abandon1010NoNo
18903140PHARMACEUTICAL COMPOSITIONSOctober 2024July 2025Abandon1010NoNo
18775679READY-TO-USE PHENYLEPHRINE FORMULATIONS AND PRODUCTSJuly 2024April 2025Allow911NoNo
18759360LAG-3 ANTAGONIST THERAPY FOR LUNG CANCERJune 2024December 2025Allow1821NoNo
18749727GASTRORETENTIVE DOSAGE FORMS FOR SUSTAINED DRUG DELIVERYJune 2024August 2025Abandon1410NoNo
18718795CLEAVABLE COMONOMER STRATEGY FOR ACCELERATING REMOVAL OF GEL NAIL POLISHJune 2024March 2025Allow910YesNo
18737301THIOPHENE ACETIC ACID FOR PLANT GROWTH REGULATIONJune 2024March 2025Abandon910NoNo
18734030HIGH CONCENTRATION PROTEIN FORMULATIONJune 2024November 2025Abandon1801NoNo
18733167Aqueous Hop Extracts and Their Use as Antimicrobial AgentsJune 2024February 2026Allow2020NoNo
18679621PHARMACEUTICAL COMPOSITIONSMay 2024September 2024Allow310NoNo
18675717HYDROGEN PEROXIDE AND PERACID STABILIZATION WITH MOLECULES BASED ON A PYRIDINE CARBOXYLIC ACIDMay 2024May 2025Allow1110NoNo
18658011HYDROGEL MEDIUM FOR THE STORAGE AND PRESERVATION OF TISSUEMay 2024April 2025Allow1101NoNo
18654689METHOD OF CONTROLLING WEEDS IN WARM SEASON TURFGRASSMay 2024August 2025Abandon1510NoNo
18646827USE OF PHOSPHATE-SOLUBILIZING MICROORGANISMS AND LIPO-CHITOOLIGOSACCHARIDES FOR ENHANCING PLANT GROWTHApril 2024July 2025Allow1410YesNo
18646956N-[(1-PHENYL-4H-1,2,4-TRIAZOL-3-YL)CARBAMOTHIOYL]BENZAMIDE AS AN ECO-FRIENDLY INSECTICIDAL AGENT AGAINST SPODOPTERA LITTORALISApril 2024July 2024Allow200NoNo
18645906AGRICULTURAL COMPOSITIONS AND METHODS OF USE THEREOFApril 2024May 2025Allow1210NoNo
18638945LIPO-CHITOOLIGOSACCHARIDE COMPOSITIONS FOR ENHANCING PLANT GROWTHApril 2024December 2025Allow2020NoYes
18636988AGRICULTURAL COMPOSITIONS COMPRISING REMODELED NITROGEN FIXING MICROBESApril 2024February 2025Allow1020YesNo
18633019Fungicidal CompositionApril 2024February 2026Allow2220YesNo
18615183PLANT ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREOFMarch 2024July 2025Allow1510NoNo
18608107Fungicidal CompositionsMarch 2024November 2025Abandon2010NoNo
18602677COMPOSITION FOR SKIN WHITENING COMPRISING CARVEDILOLMarch 2024June 2025Abandon1610NoNo
18583237HUMAN NASAL TURBINATE-DERIVED MESENCHYMAL STEM CELL-BASED, 3D BIOPRINTED CONSTRUCT, AND USE THEREOFFebruary 2024June 2025Allow1610NoNo
184297572-(BENZO[D]OXAZOL-2-YL)-N'- (ISONICOTINOYLOXY)ACETIMIDAMIDE AS AN ANTIMICROBIAL COMPOUNDFebruary 2024August 2024Allow710YesNo
184297522-(BENZO[D]OXAZOL-2-YL)-N'- (ISONICOTINOYLOXY)ACETIMIDAMIDE AS AN ANTIMICROBIAL COMPOUNDFebruary 2024August 2024Allow610YesNo
18425739Sustained Release Compositions Comprising Micronized TolcaponeJanuary 2024September 2024Allow800NoNo
18293034AGRICULTURAL APPLICATIONS OF FATTY ACID REACTION PRODUCTS OF DEXTRINS OR DEXTRANJanuary 2024September 2025Allow2020NoNo
18419071Termite Trailing and Recruitment Product and ProcessJanuary 2024September 2024Allow820YesNo
18406089METHODS FOR CARBON CAPTURE AND INCREASING YIELD OF PLANTSJanuary 2024May 2024Allow400NoNo
18396296COMPOSITIONS AND METHODS FOR SCALABLE PRODUCTION AND DELIVERY OF BIOLOGICALSDecember 2023September 2024Allow811NoNo
18540318AGRICULTURAL COMPOSITIONS COMPRISING REMODELED NITROGEN FIXING MICROBESDecember 2023December 2024Allow1211NoNo
18565464METHODS FOR CARBON CAPTURE AND INCREASING YIELD OF PLANTSNovember 2023February 2025Allow1510NoNo
18512553ANTIPATHOGENIC FIBROUS MATERIALNovember 2023October 2025Allow2320YesNo
18508977NOVEL CURCUMIN DERIVATIVE WITH ENHANCED ANTIOXIDANT PROPERTIESNovember 2023August 2025Abandon2141NoYes
18389272COMPOSITION AND METHOD FOR TREATING COVID-19November 2023March 2026Allow2831YesNo
18382913N-[(1-PHENYL-4H-1,2,4-TRIAZOL-3-YL)CARBAMOTHIOYL]BENZAMIDE AS AN ECO-FRIENDLY INSECTICIDAL AGENT AGAINST SPODOPTERA LITTORALISOctober 2023March 2024Allow501NoNo
183827312-(BENZO[D]OXAZOL-2-YL)-N'- (ISONICOTINOYLOXY)ACETIMIDAMIDE AS AN ANTIMICROBIAL COMPOUNDOctober 2023October 2024Allow1221YesNo
18490248Triple Negative Breast Cancer Treatment MethodOctober 2023May 2025Abandon1911NoNo
18490070ANTIMICROBIAL AGENT FOR COATING COMPOSITIONOctober 2023January 2026Allow2730YesNo
18486860VIP and VIP Agonists, Nanoparticles, and Uses in Inflammatory T-Cell Mediated DiseaseOctober 2023March 2026Allow2910YesNo
18379281Herbicidal Compositions Including Drift Retardant Agents And Methods Of Making The SameOctober 2023May 2025Allow1910NoNo
18484474METHOD FOR CONTROLLING PESTS OF FARM CROPSOctober 2023July 2025Allow2120NoNo
18376765APPLICATION OF STRUCTURALLY ALTERED GAS MOLECULES TO ENHANCE PRODUCTION OF ADENOSINE TRIPHOSPHATE IN LIVING ORGANISMS WITH NO INCREASE IN REACTIVE OXYGEN SPECIESOctober 2023March 2024Allow511YesNo
18479990An Extended-Release Pharmaceutical Formulation of Viloxazine And Process For Preparation ThereofOctober 2023February 2026Abandon2941YesYes
18476743MULTI-LAYER TRUE SPHERICAL CHITOSAN ENCAPSULATION OF ABSOLUTE (ESSENTIAL) OILS FOR USE IN PESTICIDAL ACTIVITYSeptember 2023November 2025Allow2500NoNo
18282137COSMETIC PRODUCT WITH SURFACE DECORATION OF DYNAMIC IMAGESSeptember 2023February 2026Allow2910NoNo
18367829Termite Trailing and Recruitment Product and ProcessSeptember 2023June 2024Abandon910NoNo
18465067POST-EMERGENCE HERBICIDESeptember 2023February 2026Allow2920NoNo
18238934Thiophene Acetic Acid for Plant Growth RegulationAugust 2023March 2024Allow610YesNo
18238883COMPOSITION FOR GENERATION OF CHLORINE DIOXIDE FOR USE AS SANITIZERAugust 2023March 2026Abandon3110NoNo
18237978NANOCRYSTALLINE TIO2 AND ZNO ORGANOSELENIUM SCAFFOLDS POSSESING DISELENIDE (SE-SE) FUNCTIONALITY FOR BIOMEDICAL TECHNOLOGYAugust 2023August 2025Abandon2440NoNo
18452223COMPOSITIONS AND METHODS FOR SCALABLE PRODUCTION AND DELIVERY OF BIOLOGICALSAugust 2023February 2025Allow1821NoNo
18452079ANTI-VIRAL PAINTS AND COATINGS AND ARTICLES COMPRISING SAMEAugust 2023December 2024Allow1621NoNo
18234250PROTOPORPHYRINOGEN OXIDASE INHIBITORSAugust 2023October 2025Allow2620YesNo
18233409ANTIMICROBIAL SILVER IODATEAugust 2023March 2025Allow1910YesNo
18446645CONTROLLING WATER RELEASE FROM A DIMENSIONALLY STABLE AQUEOUS COMPOSITIONAugust 2023June 2025Allow2210YesNo
18231449GASTRORETENTIVE DOSAGE FORMS FOR SUSTAINED DRUG DELIVERYAugust 2023March 2024Allow720YesNo
18276036URACIL COMPOUND CONTAINING CARBOXYLATE FRAGMENT, PREPARATION METHOD THEREFOR, AND HERBICIDAL COMPOSITION AND USE THEREOFAugust 2023February 2024Allow601YesNo
18365870LIQUID AGRICULTURAL COMPOSITIONS, AND METHODS OF PREPARATION AND USE THEREOFAugust 2023March 2025Allow2010NoNo
18230045HIGH CONCENTRATION GLYPHOSATE AGROCULTURAL MATERIAL AND METHOD FOR USEAugust 2023September 2025Allow2500NoNo
18230103ORGANIC CONTACT HERBICIDE AND METHOD OF USE THEREOFAugust 2023August 2024Allow1300NoNo
18363626FUNGAL ENDOPHYTES FOR IMPROVED CROP YIELDS AND PROTECTION FROM PESTSAugust 2023April 2025Abandon2110NoNo
18361242METFORMIN INHALATION POWDER AEROSOL FOR TREATING IDIOPATHIC PULMONARY FIBROSIS AND PREPARATION METHOD THEREOFJuly 2023December 2025Allow2910NoNo
18359099METHODS FOR THE CONTROL OF ARTHROPODS USING NEAR-IDEAL GAS PHASE HYDROGEN PEROXIDEJuly 2023December 2024Allow1610YesNo
18359316PICOLINAMIDE COMPOUNDS WITH FUNGICIDAL ACTIVITYJuly 2023February 2024Allow700YesNo
18225739GROWTH REGULATOR CONCENTRATE AND USE THEREOFJuly 2023September 2025Allow2610NoNo
18225852SODIUM THIOSULFATE-CONTAINING PHARMACEUTICAL COMPOSITIONSJuly 2023September 2024Abandon1310YesNo
18357957INSECT REPELLANT-INFUSED DISPOSABLE ARTICLESJuly 2023April 2025Allow2110NoNo
18356676INSECT REPELLANT-INFUSED DISPOSABLE ARTICLESJuly 2023April 2025Allow2110NoNo
18355800PROTOPORPHYRINOGEN OXIDASE INHIBITORSJuly 2023September 2023Allow200NoNo
18354557MICROALGAE-BASED COMPOSITIONS FOR BENEFITING PLANTS AND METHODS OF APPLICATIONJuly 2023July 2025Allow2420YesNo
18352500SOLUTIONS AND METHODS FOR FORMING AN EXOGENOUS FLEXIBLE FILM ON A PLANT AND PLANTS INCLUDING THE EXOGENOUS FLEXIBLE FILMJuly 2023March 2025Allow2020YesNo
18219277BIOPESTICIDE FORMULATION AND TREATMENT METHOD THEREOFJuly 2023December 2024Allow1830YesNo
18218502Purified and Enhanced Hydrogen Peroxide Disinfecting Solution for the Rapid Inactivation of COVID-19 and Other PathogensJuly 2023March 2026Abandon3210NoNo
18346642KITS FOR MANUFACTURING INHALABLE FORMULATIONS OF MEDICINAL CANNABIS COMPOUNDS FOR AEROSOL DEVICES, APPARATUSES, AND METHODS FOR MAKING AND USING THE SAMEJuly 2023June 2025Abandon2310NoNo
18217105TRANSDERMAL FORMULATION FOR THE TREATMENT OF PAIN AND/OR INFLAMMATIONJune 2023April 2025Allow2110NoNo
18268687NEW COMPOSITION FOR CURLING HAIRJune 2023February 2026Abandon3210NoNo
18338657MICROENCAPSULATION PROCESS AND PRODUCTJune 2023March 2025Abandon2110NoNo
18211954Stable 1-Methylcyclopropene Compositions and Uses ThereofJune 2023February 2026Allow3220YesNo
18337341BIODEGRADABLE POLYMER FORMULATIONS FOR EXTENDED EFFICACY OF BOTULINUM TOXINJune 2023December 2024Allow1800YesNo
18336379METHOD OF TREATING CANCERJune 2023May 2025Abandon2320YesNo
18335974LIPOCATIONIC DENDRIMERS AND USES THEREOFJune 2023February 2024Allow810NoNo
18335960LIPOCATIONIC DENDRIMERS AND USES THEREOFJune 2023January 2024Allow810NoNo
18267353SYNERGISTIC HERBICIDAL COMPOSITIONS OF METAMIFOPJune 2023February 2026Abandon3210NoNo
18333891PATHOGENIC CONTROL COMPOSITIONS AND METHODSJune 2023January 2026Abandon3110NoNo
18206647ANTIMICROBIAL COMPOSITIONJune 2023March 2026Abandon3310NoNo
18206263SEED MATERIAL PELLETSJune 2023February 2025Allow2010NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for art-unit 1616.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
489
Examiner Affirmed
383
(78.3%)
Examiner Reversed
106
(21.7%)
Reversal Percentile
7.6%
Lower than average

What This Means

With a 21.7% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
2125
Allowed After Appeal Filing
436
(20.5%)
Not Allowed After Appeal Filing
1689
(79.5%)
Filing Benefit Percentile
8.3%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 20.5% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Art Unit 1616 - Prosecution Statistics Summary

Executive Summary

Art Unit 1616 is part of Group 1610 in Technology Center 1600. This art unit has examined 16,327 patent applications in our dataset, with an overall allowance rate of 47.9%. Applications typically reach final disposition in approximately 34 months.

Comparative Analysis

Art Unit 1616's allowance rate of 47.9% places it in the 6% percentile among all USPTO art units. This art unit has a significantly lower allowance rate than most art units at the USPTO.

Prosecution Patterns

Applications in Art Unit 1616 receive an average of 2.22 office actions before reaching final disposition (in the 74% percentile). The median prosecution time is 34 months (in the 32% percentile).

Strategic Considerations

When prosecuting applications in this art unit, consider the following:

  • The art unit's allowance rate suggests a more challenging examination environment compared to the USPTO average.
  • With more office actions than average, plan for relatively streamlined prosecution.
  • The median prosecution time is longer than average and should be factored into your continuation and client communication strategies.
  • Review individual examiner statistics within this art unit to identify examiners with particularly favorable or challenging prosecution patterns.

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.